NLS Careers article

The planned restructuring would result in an approximately 20-25% reduction in the current workforce and will result in approximately SEK 75-85 million in annual savings when implemented. The restructuring is subject to negotiation with relevant trade unions. While we firmly believe this initiative is a necessary action to help us deliver on our mission, it […]

Stefan K. Nilsson, CEO of Lipigon, describes the life science environment in Umeå and shares his favorite spots. Describe the vibe in Umeå for a company like yours! “The environment is characterized by a friendly atmosphere where people are always willing to help. New entrepreneurs have a lot of knowledge to tap into. In most […]

For the past 14 years Jutta Heix has been an important cog in the wheel in accelerating the development of new cancer treatments and diagnostics – connecting and helping innovators and putting Norwegian oncology on the global map.

Sobi has announced that its contract with Pfizer for the manufacture of drug substance for ReFacto AF/Xyntha (ReFacto) has been amended due to clarity of final order volumes and will now expire in the first quarter of 2024, earlier than the previous expiry date at the end of 2025. Manufacturing of drug substance for ReFacto […]

Key2Compliance is expanding outside Sweden’s borders for the first time. Recruitment has already started for the Danish office in Copenhagen, states the company in a press release. ”We already have a number of Danish customers and have completed numerous courses and training there. This was a natural step,” says CEO Jan Hellqvist. Continue the growth […]

The purpose of the new professorship is to promote cancer research that moves patient care towards a more individualized direction. On the World Cancer Day of 4 February it was announced that Finland’s first professorship for individualized cancer treatment will be established in connection with the University of Helsinki and Helsinki University Hospital. ”A professorship […]